Table 2 Characteristics of eligible studies for clinicopathological features
Study | Year | Country | Tumor type | Samplesize | Male/Female | High/Low C5aR | Clinicopathologic Features |
|---|---|---|---|---|---|---|---|
Zhao et al. | 2018 | China | NSCLC | 185 | 128/57 | 104/81 | Tumor size, Lymph node metastasis, TNM stage, Pathologic type |
Kaida et al. | 2016 | Japan | GC | 100 | 64/36 | 35/65 | Tumor location, Differentiation, Depth of invasion, Lymph node metastasis, pStage, Lymphatic invasion, Vascular invasion |
Hu et al. | 2016 | China | HCC | 78 | 51/27 | 53/25 | Tumor size, Tumor numbers, Capsular invasion, E-cadherin expression, Snail expression, Claudin-1 expression, Pathological grade, Tumor stage |
Wada et al. | 2016 | Japan | UCC | 52 | 39/13 | 38/14 | Tumor location, WHO grade, T stage, Blood vessel invasion, Lymph node invasion, Stage of disease |
Imamura et al. | 2020 | Japan | PC | 161 | NA | 32/129 | Gleason grade, Pathological Tstage, PD-L1 expression |
Maeda et al. | 2015 | Japan | RCC | 127 | 86/41 | 78/49 | Histological subtypes, Fuhrman grade, TNM stage, microscopic invasion |
Xi et al. | 2016 | China | RCC | 272 | 188/84 | 141/131 | Tumor size, Fuhrman grade, Necrosis, TNM stage, ECOG-PS |
Nitta et al. | 2016 | Japan | GC | 148 | 108/40 | 45/103 | Tumor size, Location, Differentiation, Invasion depth, N classification, pStage, Lymphatic invasion, Vascular invasion, Amount of interstitial connective tissue, Infiltrative pattern |
Imamura et al. | 2015 | Japan | BC | 171 | 0/171 | 22/149 | Menopause, Pathological tumor size, nuclear grade, Ki-67 labeling index, Nodular status, Clinical stages, Estrogen receptor (ER), Estrogen receptor (ER), HRE2, Tumor subtype |
Gu et al. | 2013 | China | NSCLC | 208 | 148/60 | 111/97 | Smoking status, Histological type, Tumor stage, Lymph node metastasis, Tumor size, Differentiation |